Hypera Pharma Overview

  • Founded
  • 2001
Founded
  • Status
  • Public
  • Employees
  • 7,515
Employees
  • Stock Symbol
  • HYPE3
Stock Symbol
  • Investments
  • 16
  • Share Price
  • $6.69
  • (As of Friday Closing)

Hypera Pharma General Information

Description

Hypera SA is a specialty and generic drug manufacturing company. The company has a focus on the major pharmaceutical segments of the Brazilian market, along with a presence in nonprescription drugs and branded generics. Hypermarcas also possesses a share of generic medicines and prescription products. The company also has a wide sales and distribution structure.

Contact Information

Formerly Known As
Hypermarcas
Ownership Status
Publicly Held
Financing Status
Private Equity-Backed
Primary Industry
Pharmaceuticals
Other Industries
Personal Products
Household Products
Stock Exchange
BSP
Primary Office
  • Avenida Magalhaes de Castro, 4800
  • 24° andar, Edifício Continental Tower, Bairro Cidade Jardim
  • Sao Paulo, SP 05502-001
  • Brazil
+55 (11) 0000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Hypera Pharma Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$6.69 $6.55 $4.62 - $9.56 $4.24B 633M 3.74M $0.40

Hypera Pharma Financials Summary

In Thousands,
USD
TTM 30-Sep-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018 FY 2017 31-Dec-2017
EV 3,304,239 5,460,687 4,755,744 6,916,263
Revenue 803,541 834,815 1,019,019 1,095,043
EBITDA 281,396 312,375 367,494 415,775
Net Income 252,284 294,942 309,073 301,909
Total Assets 3,030,322 2,961,728 2,724,123 3,056,861
Total Debt 989,519 348,517 145,614 198,047
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Hypera Pharma Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Hypera Pharma‘s full profile, request access.

Request a free trial

Hypera Pharma Executive Team (1)

Name Title Board Seat Contact Info
Claudio Bergamo Chief Executive Officer
To view Hypera Pharma’s complete executive team members history, request access »

Hypera Pharma Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Hypera Pharma Investments & Acquisitions (16)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000 0000000 000 04-Dec-2020 000000000000000000 Personal Products
000000 00000000000 02-Mar-2020 000000000000000000 00000 Pharmaceuticals
0000000000 0000000 18-Dec-2019 000000000 00000 00 00000 Buildings and Property
000000000 000ú0000 24-Jan-2011 000000000000000000 00.000 Pharmaceuticals 0000000 0000000
Comercial Maripa 25-Nov-2010 Merger/Acquisition Personal Products 0000000 0000000
You’re viewing 5 of 16 investments and acquisitions. Get the full list »

Hypera Pharma Subsidiaries (4)

Company Name Industry Location Founded
Simple Organic Beauty Personal Products Florianópolis, Brazil 2016
000000 - 000ú00000 Personal Products Aparecida de Goiania, Brazil 0000
00000000000 000 00 Pharmaceuticals Anápolis, Brazil 0000
00000000 Medical Supplies Curitiba, Brazil
To view Hypera Pharma’s complete subsidiaries history, request access »

Hypera Pharma Exits (1)

Company Name Exit Date Exit Type Exit Size Status Buyers
00000000000(000000 01-Jan-2008 000000000000000000 Completed
  • 000000 000000
To view Hypera Pharma’s complete exits history, request access »